1. Home
  2. EW vs HLN Comparison

EW vs HLN Comparison

Compare EW & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EW
  • HLN
  • Stock Information
  • Founded
  • EW 1958
  • HLN 2022
  • Country
  • EW United States
  • HLN United Kingdom
  • Employees
  • EW N/A
  • HLN N/A
  • Industry
  • EW Industrial Specialties
  • HLN Package Goods/Cosmetics
  • Sector
  • EW Health Care
  • HLN Consumer Discretionary
  • Exchange
  • EW Nasdaq
  • HLN Nasdaq
  • Market Cap
  • EW 44.8B
  • HLN 48.2B
  • IPO Year
  • EW 2000
  • HLN N/A
  • Fundamental
  • Price
  • EW $79.32
  • HLN $9.68
  • Analyst Decision
  • EW Buy
  • HLN Buy
  • Analyst Count
  • EW 20
  • HLN 1
  • Target Price
  • EW $85.00
  • HLN $10.95
  • AVG Volume (30 Days)
  • EW 5.1M
  • HLN 12.4M
  • Earning Date
  • EW 07-24-2025
  • HLN 08-12-2025
  • Dividend Yield
  • EW N/A
  • HLN 1.84%
  • EPS Growth
  • EW 188.87
  • HLN 38.94
  • EPS
  • EW 7.02
  • HLN 0.23
  • Revenue
  • EW $5,685,100,000.00
  • HLN $15,096,588,575.00
  • Revenue This Year
  • EW $12.97
  • HLN $1.93
  • Revenue Next Year
  • EW $9.65
  • HLN $4.10
  • P/E Ratio
  • EW $33.19
  • HLN $20.86
  • Revenue Growth
  • EW 9.49
  • HLN N/A
  • 52 Week Low
  • EW $59.41
  • HLN $8.86
  • 52 Week High
  • EW $83.00
  • HLN $11.42
  • Technical
  • Relative Strength Index (RSI)
  • EW 56.40
  • HLN 41.22
  • Support Level
  • EW $75.39
  • HLN $9.41
  • Resistance Level
  • EW $81.88
  • HLN $9.85
  • Average True Range (ATR)
  • EW 1.78
  • HLN 0.13
  • MACD
  • EW 0.27
  • HLN 0.02
  • Stochastic Oscillator
  • EW 52.14
  • HLN 47.79

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: